ImmunoGen, Inc. Announces Favorable Update Provided By Roche Related To Its Trastuzum

		HER2 Support Group Forums > Breast Cancer Newsfeed
ImmunoGen, Inc. Announces Favorable Update Provided By Roche Related To Its Trastuzum

04-15-2010, 06:15 PM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,983	ImmunoGen, Inc. Announces Favorable Update Provided By Roche Related To Its Trastuzum ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer products, today announced that Roche has provided a favorable update related to its plans to apply for marketing approval of trastuzumab-DM1 (T-DM1) in the US... More...

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Forum Rules

All times are GMT -7. The time now is 09:34 PM.